Similar Papers

Paper Title
Journal
Date
Author
What Is the Optimal Time to Initiate Hypomethylating Agents (HMA) in Higher Risk Myelodysplastic Syndromes (MDS)?
Rami S Komrokji ... Alan F List
Blood | VOL. 132
Rami S Komrokji, et. al.Rami S Komrokji ... Alan F List
29 Nov 2018
Micrornas Analysis in Patients with Myelodysplastic Syndrome. Possible Implications in Risk Stratification
Christina-Nefeli Kontandreopoulou ... Nora-Athina Viniou
Blood | VOL. 140
Christina-Nefeli Kontandreopoulou, et. al.Christina-Nefeli Kontandreopoulou ... Nora-Athina Viniou
15 Nov 2022
Analysis of Survival Gains in Myelodysplastic Syndromes after a Decade of the Modern Treatment Paradigm
Diego Adrianzen Herrera ... Neil A Zakai
Blood | VOL. 138
Diego Adrianzen Herrera, et. al.Diego Adrianzen Herrera ... Neil A Zakai
05 Nov 2021
Azacitidine (AZA) and Decitabine (DAC) Show Differential Effects On DNA Methyltransferase (DNMT) Levels in Patients with High Risk (HR) Myelodysplastic Syndrome (MDS)
Aileen Cohen ... Steven M Kornblau
Blood | VOL. 120
Aileen Cohen, et. al.Aileen Cohen ... Steven M Kornblau
16 Nov 2012
View more papers

More From: Blood

Paper Title
Journal
Date
Author
Advances in RNA editing in hematopoiesis and associated malignancies.
Shuangshuang Pu ... Hui Cheng
Blood | VOL. -
Shuangshuang Pu, et. al.Shuangshuang Pu ... Hui Cheng
27 Jan 2025
Protection of β2GPI-Deficient Mice from Thrombosis Reflects a Defect in PAR3-facilitated Platelet Activation.
Paresh P Kulkarni ... Keith R Mccrae
Blood | VOL. -
Paresh P Kulkarni, et. al.Paresh P Kulkarni ... Keith R Mccrae
27 Jan 2025
Babesiosis and Sickle Red blood Cells: Loss of Deformability, Heightened Osmotic fragility, and Hypervesiculation.
Divya Beri ... Cheryl A Lobo
Blood | VOL. -
Divya Beri, et. al.Divya Beri ... Cheryl A Lobo
27 Jan 2025
Platelet activation and signaling in thrombus formation.
Frauke Swieringa ... Alice Assinger
Blood | VOL. -
Frauke Swieringa, et. al.Frauke Swieringa ... Alice Assinger
27 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.